{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:38:28Z","timestamp":1792100308514,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Est\u00e9e Lauder University Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10549-021-06477-0","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T06:04:44Z","timestamp":1641276284000},"page":"293-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer"],"prefix":"10.1007","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-5457","authenticated-orcid":false,"given":"Annemarie","family":"Coolbrandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Vancoille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dejaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Laenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1434-9460","authenticated-orcid":false,"given":"P.","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-7963","authenticated-orcid":false,"given":"K.","family":"Punie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8990-7837","authenticated-orcid":false,"given":"H.","family":"Wildiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"issue":"26","key":"6477_CR1","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1200\/JCO.2012.48.1275","volume":"31","author":"SM Swain","year":"2013","unstructured":"Swain SM, Tang G, Geyer CE Jr, Rastogi P, Atkins JN, Donnellan PP, Fehrenbacher L, Azar CA, Robidoux A, Polikoff JA et al (2013) Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. J Clin Oncol 31(26):3197\u20133204","journal-title":"J Clin Oncol"},{"issue":"3","key":"6477_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1078155208100450","volume":"15","author":"P Gilbar","year":"2009","unstructured":"Gilbar P, Hain A, Peereboom VM (2009) Nail toxicity induced by cancer chemotherapy. J Oncol Pharm Pract 15(3):143\u2013155","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"6477_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1188\/04.CJON.527-528","volume":"8","author":"J Marrs","year":"2004","unstructured":"Marrs J, Newton S (2004) Chemotherapy-induced nail changes: an unsightly nuisance. Clin J Oncol Nurs 8(5):527\u2013528","journal-title":"Clin J Oncol Nurs"},{"issue":"2","key":"6477_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/annonc\/mdg050","volume":"14","author":"AM Minisini","year":"2003","unstructured":"Minisini AM, Tosti A, Sobrero AF, Mansutti M, Piraccini BM, Sacco C, Puglisi F (2003) Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol 14(2):333\u2013337","journal-title":"Ann Oncol"},{"issue":"1","key":"6477_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.3.1.57","volume":"3","author":"BM Piraccini","year":"2004","unstructured":"Piraccini BM, Iorizzo M, Antonucci A, Tosti A (2004) Drug-induced nail abnormalities. Expert Opin Drug Saf 3(1):57\u201365","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"6477_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejon.2008.10.003","volume":"13","author":"J Baker","year":"2009","unstructured":"Baker J, Ajani J, Scotte F, Winther D, Martin M, Aapro MS, von Minckwitz G (2009) Docetaxel-related side effects and their management. Eur J Oncol Nurs 13(1):49\u201359","journal-title":"Eur J Oncol Nurs"},{"issue":"3","key":"6477_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1684\/ejd.2013.2048","volume":"23","author":"E Belyayeva","year":"2013","unstructured":"Belyayeva E, Gregoriou S, Chalikias J, Kontochristopoulos G, Koumantaki E, Makris M, Koti I, Katoulis A, Katsambas A, Rigopoulos D (2013) The impact of nail disorders on quality of life. Eur J Dermatol 23(3):366\u2013371","journal-title":"Eur J Dermatol"},{"issue":"7","key":"6477_CR8","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/cncr.23333","volume":"112","author":"F Scotte","year":"2008","unstructured":"Scotte F, Banu E, Medioni J, Levy E, Ebenezer C, Marsan S, Banu A, Tourani JM, Andrieu JM, Oudard S (2008) Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot. Cancer 112(7):1625\u20131631","journal-title":"Cancer"},{"issue":"19","key":"6477_CR9","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1200\/JCO.2005.15.651","volume":"23","author":"F Scotte","year":"2005","unstructured":"Scotte F, Tourani JM, Banu E, Peyromaure M, Levy E, Marsan S, Magherini E, Fabre-Guillevin E, Andrieu JM, Oudard S (2005) Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol 23(19):4424\u20134429","journal-title":"J Clin Oncol"},{"issue":"12","key":"6477_CR10","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1001\/jamadermatol.2018.3465","volume":"154","author":"DH Marks","year":"2018","unstructured":"Marks DH, Qureshi A, Friedman A (2018) Evaluation of prevention interventions for taxane-induced dermatologic adverse events: a systematic review. JAMA Dermatol 154(12):1465\u20131472","journal-title":"JAMA Dermatol"},{"issue":"5","key":"6477_CR11","doi-asserted-by":"publisher","first-page":"e13118","DOI":"10.1111\/ecc.13118","volume":"28","author":"KL Huang","year":"2019","unstructured":"Huang KL, Lin KY, Huang TW, Loh EW, Hua YM, Su HC, Tam KW (2019) Prophylactic management for taxane-induced nail toxicity: A systematic review and meta-analysis. Eur J Cancer Care (Engl) 28(5):e13118","journal-title":"Eur J Cancer Care (Engl)"},{"key":"6477_CR12","doi-asserted-by":"crossref","unstructured":"Lacouture ME, Sibaud V, Gerber PA, van den Hurk C, Fernandez-Penas P, Santini D, Jahn F, Jordan K, clinicalguidelines@esmo.org EGCEa: Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines(). Ann Oncol 2021, 32(2):157\u2013170.","DOI":"10.1016\/j.annonc.2020.11.005"},{"issue":"1","key":"6477_CR13","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1186\/s12885-018-4869-5","volume":"18","author":"Z Ghoreishi","year":"2018","unstructured":"Ghoreishi Z, Keshavarz S, Asghari Jafarabadi M, Fathifar Z, Goodman KA, Esfahani A (2018) Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer. BMC Cancer 18(1):958","journal-title":"BMC Cancer"},{"issue":"16","key":"6477_CR14","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa0707056","volume":"358","author":"JA Sparano","year":"2008","unstructured":"Sparano JA, Wang M, Martino S, Jones V, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE (2008) Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 358(16):1663\u20131671","journal-title":"N Engl J Med"},{"issue":"1","key":"6477_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10549-013-2728-2","volume":"142","author":"L Eckhoff","year":"2013","unstructured":"Eckhoff L, Knoop AS, Jensen MB, Ejlertsen B, Ewertz M (2013) Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer. Breast Cancer Res Treat 142(1):109\u2013118","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"6477_CR16","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/IGC.0000000000001320","volume":"28","author":"H Matsuoka","year":"2018","unstructured":"Matsuoka H, Nakamura K, Matsubara Y, Ida N, Saijo M, Ogawa C, Masuyama H (2018) The influence of chemotherapy-induced peripheral neuropathy on quality of life of gynecologic cancer survivors. Int J Gynecol Cancer 28(7):1394\u20131402","journal-title":"Int J Gynecol Cancer"},{"issue":"28","key":"6477_CR17","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, Kelley MR, Lavino A, Lustberg MB, Paice JA et al (2020) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol 38(28):3325\u20133348","journal-title":"J Clin Oncol"},{"issue":"10","key":"6477_CR18","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","volume":"31","author":"B Jordan","year":"2020","unstructured":"Jordan B, Margulies A, Cardoso F, Cavaletti G, Haugnes HS, Jahn P, Le Rhun E, Preusser M, Scotte F, Taphoorn MJB et al (2020) Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol 31(10):1306\u20131319","journal-title":"Ann Oncol"},{"issue":"2","key":"6477_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/jnci\/djx178","volume":"110","author":"A Hanai","year":"2018","unstructured":"Hanai A, Ishiguro H, Sozu T, Tsuda M, Yano I, Nakagawa T, Imai S, Hamabe Y, Toi M, Arai H et al (2018) Effects of cryotherapy on objective and subjective symptoms of paclitaxel-induced neuropathy: prospective self-controlled trial. J Natl Cancer Inst 110(2):141\u2013148","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"6477_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.annonc.2019.09.006","volume":"31","author":"AJM Beijers","year":"2020","unstructured":"Beijers AJM, Bonhof CS, Mols F, Ophorst J, de Vos-Geelen J, Jacobs EMG, van de Poll-Franse LV, Vreugdenhil G (2020) Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy. Ann Oncol 31(1):131\u2013136","journal-title":"Ann Oncol"},{"issue":"10","key":"6477_CR21","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1007\/s00520-018-4199-9","volume":"26","author":"C Griffiths","year":"2018","unstructured":"Griffiths C, Kwon N, Beaumont JL, Paice JA (2018) Cold therapy to prevent paclitaxel-induced peripheral neuropathy. Support Care Cancer 26(10):3461\u20133469","journal-title":"Support Care Cancer"},{"issue":"5","key":"6477_CR22","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00520-013-2095-x","volume":"22","author":"AL McCarthy","year":"2014","unstructured":"McCarthy AL, Shaban RZ, Gillespie K, Vick J (2014) Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial. Support Care Cancer 22(5):1375\u20131383","journal-title":"Support Care Cancer"},{"key":"6477_CR23","doi-asserted-by":"publisher","first-page":"153473542094328","DOI":"10.1177\/1534735420943287","volume":"19","author":"E Oneda","year":"2020","unstructured":"Oneda E, Meriggi F, Zanotti L, Zaina E, Bighe S, Andreis F, Rueda S, Zaniboni A (2020) Innovative approach for the prevention of chemotherapy-induced peripheral neuropathy in cancer patients: a pilot study with the hilotherm device, the poliambulanza hospital experience. Integr Cancer Ther 19:1534735420943287","journal-title":"Integr Cancer Ther"},{"key":"6477_CR24","unstructured":"Hilotherm GmbH H: 10\u201312\u00b0 Hilotherapy for the prevention of polyneuropathy (CIPN) and hand-foot syndrome (HFS). In.: Hilotherm GmbH; 2020. https:\/\/www.hilotherm.com\/wp-content\/uploads\/2020\/08\/HT_ChemoCare_Broschuere_EN_NEU2020_web.pdf."},{"key":"6477_CR25","doi-asserted-by":"crossref","unstructured":"Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP et al (2014) Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 106(9):244","DOI":"10.1093\/jnci\/dju244"},{"issue":"6","key":"6477_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jpainsymman.2019.07.021","volume":"58","author":"JM McCrary","year":"2019","unstructured":"McCrary JM, Goldstein D, Trinh T, Timmins HC, Li T, Friedlander M, Bosco A, Harrison M, Maier N, O\u2019Neill S et al (2019) Optimizing clinical screening for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manage 58(6):1023\u20131032","journal-title":"J Pain Symptom Manage"},{"issue":"12","key":"6477_CR27","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1038\/bjc.2014.496","volume":"111","author":"T Kalsi","year":"2014","unstructured":"Kalsi T, Babic-Illman G, Fields P, Hughes S, Maisey N, Ross P, Wang Y, Harari D (2014) The impact of low-grade toxicity in older people with cancer undergoing chemotherapy. Br J Cancer 111(12):2224\u20132228","journal-title":"Br J Cancer"},{"issue":"3","key":"6477_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejon.2011.06.007","volume":"16","author":"G Can","year":"2012","unstructured":"Can G, Aydiner A, Cavdar I (2012) Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity. Eur J Oncol Nurs 16(3):270\u2013275","journal-title":"Eur J Oncol Nurs"},{"issue":"9","key":"6477_CR29","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00520-011-1308-4","volume":"20","author":"H Ishiguro","year":"2011","unstructured":"Ishiguro H, Takashima S, Yoshimura K, Yano I, Yamamoto T, Niimi M, Yamashiro H, Ueno T, Takeuchi M, Sugie T et al (2011) Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients. Support Care Cancer 20(9):2017\u20132024","journal-title":"Support Care Cancer"},{"key":"6477_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.breast.2016.09.007","volume":"30","author":"MMC Komen","year":"2016","unstructured":"Komen MMC, Smorenburg CH, Nortier JWR, van der Ploeg T, van den Hurk CJG, van der Hoeven JJM (2016) Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature. Breast 30:105\u2013110","journal-title":"Breast"},{"issue":"1","key":"6477_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40846-018-0416-8","volume":"39","author":"A Youssef","year":"2019","unstructured":"Youssef A, D\u2019Haene M, Vleugels J, De Bruyne G, Aerts JM (2019) Localised model-based active controlling of blood flow during chemotherapy to prevent nail toxicity and onycholysis. Journal of Medical and Biological Engineering 39(1):139\u2013150","journal-title":"Journal of Medical and Biological Engineering"},{"issue":"4","key":"6477_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3109\/0284186X.2015.1075664","volume":"55","author":"A Bandla","year":"2016","unstructured":"Bandla A, Sundar R, Liao LD (2016) Sze Hui Tan S, Lee SC, Thakor NV, Wilder-Smith EP: Hypothermia for preventing chemotherapy-induced neuropathy - a pilot study on safety and tolerability in healthy controls. Acta Oncol 55(4):430\u2013436","journal-title":"Acta Oncol"},{"issue":"8","key":"6477_CR33","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1007\/s00520-019-05177-2","volume":"28","author":"A Bandla","year":"2020","unstructured":"Bandla A, Tan S, Kumarakulasinghe NB, Huang Y, Ang S, Magarajah G, Hairom Z, Lim JSJ, Wong A, Chan G et al (2020) Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy. Support Care Cancer 28(8):3691\u20133699","journal-title":"Support Care Cancer"},{"key":"6477_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.breast.2019.12.011","volume":"49","author":"Y Kanbayashi","year":"2020","unstructured":"Kanbayashi Y, Sakaguchi K, Ishikawa T, Ouchi Y, Nakatsukasa K, Tabuchi Y, Kanehisa F, Hiramatsu M, Takagi R, Yokota I et al (2020) Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial. Breast 49:219\u2013224","journal-title":"Breast"},{"issue":"8","key":"6477_CR35","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s00520-016-3297-9","volume":"24","author":"TM Atkinson","year":"2016","unstructured":"Atkinson TM, Ryan SJ, Bennett AV, Stover AM, Saracino RM, Rogak LJ, Jewell ST, Matsoukas K, Li Y, Basch E (2016) The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review. Support Care Cancer 24(8):3669\u20133676","journal-title":"Support Care Cancer"},{"key":"6477_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1200\/EDBK_200383","volume":"38","author":"E Basch","year":"2018","unstructured":"Basch E, Barbera L, Kerrigan CL, Velikova G (2018) Implementation of patient-reported outcomes in routine medical care. Am Soc Clin Oncol Educ Book 38:122\u2013134","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"11","key":"6477_CR37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","volume":"7","author":"E Basch","year":"2006","unstructured":"Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, Scher HI, Schrag D (2006) Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7(11):903\u2013909","journal-title":"Lancet Oncol"},{"key":"6477_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.breast.2019.09.011","volume":"48","author":"KJ Ruddy","year":"2019","unstructured":"Ruddy KJ, Le-Rademacher J, Lacouture ME, Wilkinson M, Onitilo AA, Vander Woude AC, Grosse-Perdekamp MT, Dockter T, Tan AD, Beutler A et al (2019) Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial. Breast 48:89\u201397","journal-title":"Breast"},{"key":"6477_CR39","doi-asserted-by":"publisher","unstructured":"Coolbrandt A, Vancoille K, Dejaeger E, Peeters H, Laenen A, Neven P, Punie K, Wildiers H (2021) Preventing taxane-related peripheral neuropathy, pain and nail toxicity: A prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer. Zenodo. https:\/\/doi.org\/10.5281\/zenodo.4478973","DOI":"10.5281\/zenodo.4478973"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-021-06477-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T16:05:48Z","timestamp":1647446748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-021-06477-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["6477"],"URL":"https:\/\/doi.org\/10.1007\/s10549-021-06477-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"28 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Ethics Committee of UZ\/KULeuven.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}